Urban Edge Properties (UE) Stock News

Nucor stock declined 1.79% on September 8, 2026, underperforming the S&P 500's 0.58% loss and lagging the Basic Materials sector. Despite strong earnings projections showing 107.60% EPS growth and 22.4% revenue growth for the upcoming quarter, the stock has lost 4.93% over the past month. Nucor holds a Zacks Rank #3 (Hold) with a Forward P/E of 14.54, slightly above its industry average.

Sky Blue Cinematix has been appointed as the exclusive worldwide brand-integration partner for two upcoming feature films from Tested Films: the action thriller 'Habeas Corpus' and the neo-noir romantic mystery 'Blurred', both directed by Ben Cookson. The partnership will connect international brands with these theatrical productions through in-film integration across all territories.

Kenvue Inc. (KVUE) demonstrated improved profitability in the first half of 2026, with adjusted operating margins rising 180 basis points to 23.1% and earnings climbing 18.9%, driven primarily by cost-cutting initiatives. However, organic sales growth remained modest at 1.2%, with the Self Care segment struggling while Skin Health and Beauty showed stronger performance. The company faces headwinds from tariffs, inflation, and $8.5 billion in debt, with a pending merger with Kimberly-Clark expected to close in Q4 2026.

Law firm Kirby McInerney LLP is investigating FuelCell Energy for potential securities fraud following the company's disclosure of $17 million in inventory charges and losses on its Fit Energy agreement. FuelCell revealed that product costs and manufacturing overhead exceed contractual pricing, causing the stock to fall 15.7% to $14.40 per share on September 2, 2026.

Revolution Medicines announced publication of Phase 1/2 clinical trial data for RASONQUE (daraxonrasib) in previously treated RAS mutant non-small cell lung cancer in the New England Journal of Medicine. The trial showed a 42% objective response rate and 16.0 months median overall survival in a docetaxel-naïve subgroup, with a manageable safety profile. Results support the ongoing Phase 3 RASolve 301 trial.

WisdomTree Multi Asset Issuer has announced an amendment to the Daily Swap Rate for its WisdomTree Silver 3x Daily Leveraged Securities, effective 1 December 2026. The rate will decrease from 0.01248% to 0.00692%, with amendment documents becoming effective on 1 September 2026. BNP Paribas acts as the Swap Provider for this change.

Onco360, the nation's leading independent specialty pharmacy, has been selected as a pharmacy partner by Revolution Medicines for the launch of RASONQUE (daraxonrasib), a RAS GTPase inhibitor for metastatic pancreatic adenocarcinoma. The drug showed significant clinical benefits in the phase 3 RASolute-302 trial, with median PFS of 7.3 months and OS of 13.2 months in RAS G12 mutation patients compared to 3.5 months and 6.6 months respectively for chemotherapy.

The FDA has approved RASONQUE (daraxonrasib), developed by Revolution Medicines, as the first targeted RAS inhibitor for treating metastatic pancreatic adenocarcinoma in patients who have received prior systemic therapy or are not candidates for multiagent chemotherapy. In the Phase 3 RASolute 302 trial, RASONQUE reduced the risk of death by 60% compared to chemotherapy, with median overall survival of 13.2 months versus 6.7 months, and demonstrated manageable safety with improved quality of life measures.

Rosen Law Firm reminds GRAIL, Inc. investors who purchased stock between May 13, 2025 and February 19, 2026 of the August 4, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that GRAIL provided misleading statements about its NHS-Galleri trial results, concealing that the trial period was insufficient to demonstrate the primary endpoint of reducing Stage III-IV cancers.

FIFA has faced backlash from global soccer governing bodies over the proposal to allow private investment.

Ferrari N.V. announced Q2 2026 net revenues of €1,938 million (up 8% YoY), operating profit of €605 million with a 31.2% margin, and net profit of €463 million. The company raised its 2026 guidance citing stronger-than-expected personalizations and lower currency headwinds. The order book covers deliveries through 2027, with new model launches including the Ferrari Luce and 12Cilindri Manuale contributing to the company's most complete product lineup in history.

Law firm Robbins Geller has filed class action lawsuits against GRAIL, Inc., GPGI, Inc., and Wix.com Ltd., alleging that executives made false and misleading statements to investors. GRAIL investors can seek lead plaintiff status by August 4, 2026, following a 50% stock price decline after the company failed to achieve primary endpoints in its NHS-Galleri cancer screening trial.

Value Line, Inc. reported fiscal year 2026 net income of $21.63 million ($2.30 per share), up 4.6% from the prior year. The company declared a quarterly dividend of $0.35 per share, marking the 12th consecutive year of increases, with an annualized rate of $1.40 per share. Investment gains nearly doubled to $6.43 million, while liquid assets increased 11.7% to $86.47 million and shareholders' equity grew 8.2% to $107.89 million.

Following ARGAN's proposed merger with WDP announced on July 23, 2026, Standard & Poor's has placed ARGAN's 'BBB-' issuer credit rating on Positive CreditWatch, indicating a potential upgrade to 'BBB' upon merger completion in Q1 2027. The combined entity would benefit from increased scale, geographic diversification, reduced tenant concentration risk, and a stronger financial profile.

ESET researchers discovered 11 old Microsoft-signed UEFI shim bootloaders with decade-old vulnerabilities that allow attackers to bypass UEFI Secure Boot on most UEFI-based systems. The vulnerable binaries, found in versions 0.9 and below from various software packages including PC-diagnostic tools and Linux distributions, have been revoked by Microsoft. Attackers can exploit these to deploy malicious UEFI bootkits even on systems with Secure Boot enabled, regardless of installed OS.

LA21-CDC received grant support from Truist Foundation to expand its Small Business Sustainability Initiative, which provides Philadelphia entrepreneurs with coaching, business systems training, capital readiness support, and AI-powered business tools to strengthen operations and build long-term sustainability.

The European Commission has approved Sanofi's Cenrifki (tolebrutinib), a brain-penetrating Bruton tyrosine kinase inhibitor, for treating secondary progressive multiple sclerosis (SPMS) without relapses. The approval is based on the Phase 3 HERCULES trial, which demonstrated that Cenrifki significantly delayed disability progression. The drug will be commercially available in Germany this year, with careful risk management protocols due to identified hepatic safety concerns.

InnSuites Hospitality Trust (IHT) reported Fiscal Q1 2027 net income of $74,702, a $35,672 improvement year-over-year, with record hotel revenue of $2.2 million and combined occupancy reaching 85.37%. The company continues exploring diversification opportunities including a potential reverse merger, IBC Hotels independent hotel services, and investments in UniGen Power's clean energy technology.

BioAge Labs announced the first participant has been dosed in QUELL-CV, a Phase 2 proof-of-concept trial evaluating BGE-102, an oral NLRP3 inhibitor for cardiovascular risk reduction. The randomized, double-blind, placebo-controlled trial will enroll approximately 160 participants with obesity and elevated inflammation across three dose levels. Phase 1 results showed BGE-102 achieved median hsCRP reductions of 86% and was well tolerated. Topline data are anticipated in the second half of 2026, with an additional Phase 1b/2a trial in diabetic macular edema planned for mid-2026.

Delivered strong Q1 2026 comparable store sales growth 1 of 22.6% and total revenue growth of 37.0% Achieved a four-year high gross margin 1 of 67.4 %, an increase of 530 bps Expanded adjusted EBITDA margin 1 to 36.8 %, underscoring our luxury-inspired business model Continued successful expansion with new stores outperforming expectations Raised adjusted EBITDA margin guidance for Fiscal 2026 to 38.25%–39.50 % MONTRÉAL , June 16, 2026 /CNW/ - Groupe Dynamite Inc. ("Groupe Dynamite" or the "Company") (TSX: GRGD ) today reported its financial results for the fiscal year 2026's first quarter ended May 2, 2026. "Our first quarter results demonstrate the strength of our operating model and our ability to deliver profitable growth. Comparable store sales increased 22.6%, gross margin reached a four-year high, and adjusted EBITDA margin expanded to 36.8% of revenue, positioning ourselves alongside the world's most profitable fashion houses. We continue to strive to remain a highly productive specialty retailer with strong brands, exceptional unit economics, disciplined inventory management, attractive returns on capital, and a growth engine we have built over decades that continues to scale profitably," said Andrew Lutfy, Chief Executive Officer and Chair of the Board. "Q1 was a strong start to fiscal 2026. Across both GARAGE and DYNAMITE, customers responded positively to our assortments, marketing campaigns and the consistency of the experience we deliver across channels. Our real estate strategy continues to be a significant driver of growth, customer acquisition and profitability. By opening new locations in premium centers, optimizing our fleet and delivering a compelling in-store experience, we continue to drive significant productivity improvements across our store network. Most importantly, we continue to see strong customer engagement across both brands, reflected

Edward Smolyansky, largest shareholder and former COO of Lifeway Foods, criticizes the Board's governance, stating the poison pill was only terminated after ISS recommended voting against all directors. He highlights a pattern of reactive governance, the reversal of a board refresh process, and calls for shareholders to vote against incumbent directors at the June 17 Annual Meeting to register dissatisfaction with the Board's conduct.

SINGAPORE , June 8, 2026 /PRNewswire/ -- VinFast Auto Ltd. announced its unaudited financial results for the first quarter ended March 31, 2026. In the first quarter of 2026, VinFast ("the Company") delivered 58,577 electric vehicles, representing an increase of 61% from the same period last year. International markets accounted for approximately 8% of total deliveries during the quarter. In Vietnam, VinFast's EV deliveries in the first quarter of 2026 increased by 53% year over year. The Company maintained its position as the number one OEM in the domestic automotive market since September 2024. Southeast Asia and India continue to be key growth markets for VinFast. At the end of the first quarter of 2026, VinFast ranked #1 BEV brand in the Philippines, #4 in India and #8 in Indonesia. The Company also delivered 143,136 units of e-scooters and e-bikes in the first quarter, representing an increase of 219% from the first quarter of 2025. In March alone, VinFast received more than 135,000 e-scooter orders and shipped over 93,000 e-scooters to dealers in Vietnam. VinFast currently holds the leading position in Vietnam's electric motorcycle market and, in March, expanded its share of the overall motorcycle market (including both ... Full story available on Benzinga.com

All amounts are unaudited and in Canadian dollars and are based on financial statements prepared in compliance with International Accounting Standard 34 Interim Financial Reporting, unless otherwise noted. Our second quarter 2026 ("Q2 2026") unaudited Interim Consolidated Financial Statements for the period ended April 30, 2026 and Management's Discussion and Analysis ("MD&A"), are available online at www.versabank.com/investor-relations , SEDAR at www.sedarplus.ca and EDGAR at www.sec.gov/edgar . Supplementary Financial Information will also be available on our website at www.versabank.com/investor-relations . LONDON, ON , June 3, 2026 /CNW/ - VersaBank (or the "Bank") (TSX: VBNK (NASDAQ: VBNK ), a North American leader in business-to-business digital banking, as well as technology solutions for cybersecurity, today reported its results for the second quarter ended April 30, 2026. All figures are in Canadian dollars unless otherwise stated. NOTE REGARDING SECOND QUARTER FISCAL 2026 FINANCIAL RESULTS VersaBank's financial results for the second quarter of fiscal 2026 reflect non-core non-interest expenses in the amount of $6.7 million. The non-core non-interest expenses included $4.5 million related to the project costs associated with the Reorganization (see Reorganization note below). Subsequent to the end of the second quarter, the Bank publicly filed a Form S-4 registration statement (the "Registration Statement") with the U.S. Securities and Exchange Commission (the "SEC") in connection with the Reorganization. The Reorganization is intended to enhance shareholder value, mitigate risk and reduce corporate costs over the long term. The Bank expects that the anticipated benefits of the Reorganization will exceed the associated investment however, these expected benefits are subject to various assumptions and uncertainties. As of the end of the second quarter of

Sika has appointed Philipp Irniger as Head Construction and member of the executive board effective June 1, 2026, succeeding Ivo Schädler who retires after 30+ years. The company also created a new Chief Digital & Information Officer position, with Jochen Werling taking the role to accelerate digital transformation and the Fast-Forward program.

Q1 Revenue Up 44% YoY; Same-Store Sales Up 29%; Adjusted EBITDA Turns Positive as Company Advances National Expansion Strategy EDMONTON, AB , June 1, 2026 /CNW/ - Dr. Phone Fix Canada Corporation (TSXV: DPF) ("Dr. Phone Fix" or the "Company"), one of Canada's fastest-growing and award-winning consumer electronics repair and resale platforms, today reported financial results for the three months ended March 31, 2026, and provided an update on recent corporate developments. The Company operates a network of 44 corporately owned stores across five Canadian provinces. Financial Results Summary (CAD) (all dollar amounts in 000's) Three Months Ended Mar 31, 2026 Three Months Ended Mar 31, 2025 Variance (%) Revenue 3,162 2,196 +44 % Gross Profit 1,621 1,210 +34 % Gross Margin 51.3 % 55.1 % -3.8 pp Operating Expenses (SG&A) 2,476 1,754 +41 % Adjusted EBITDA(1) 88 (13) n/m Cash 291 1,558 -81 % (1) See Non-GAAP Financial Measure towards the end of this document. "Q1 reflected continued progress in the execution of our strategy with revenue increasing 44% year-over-year and comparable-store sales increasing 29%, even in what is typically our seasonally weakest quarter," said Piyush Sawhney, Founder and Chief Executive Officer of Dr. Phone Fix. "We also delivered positive Adjusted EBITDA, generated positive operating cash flow, and continued to improve execution across our national network while integrating recently acquired locations and advancing our OEM, insurance, supplier, repair and certified pre-owned device programs." Mr. Sawhney continued, "We have spent the past year building the foundation for a national, carrier-neutral device lifecycle platform. Today, we have 44 corporately owned locations across five provinces, a growing pipeline of acquisition and greenfield opportunities, and a strategy focused on disciplined expansion and stronger unit-level economics throug

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p align="center"><em>Q1 2026 Revenue of $17.9M</em><br /><em>Ended quarter with $8.3 million of cash and cash equivalents</em><br /><em>Received net proceeds of $5.7 million from interim financing</em><br /><em>Continued progress on Vireo transaction and Texas divestiture</em></p> <p align="justify">TAMPA, Fla., June 01, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=dUAxyqckkUEdHWQlOcVBLierqtd2OYNadN_XBkggQSzWyBH8-ifdpW-9Teq8SbFZv21n1pHjtZ7p7bslwNuu2g==" rel="nofollow" target="_blank" rel="nofollow"><u>FLUENT Corp.</u></a> (CSE:<a class="ticker" href="https://www.benzinga.com/quote/FNT" rel="nofollow">FNT</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/quote/CNTMF" rel="nofollow">CNTMF</a>) ("FLUENT" or the "Company"), a vertically-integrated, multi-state cannabis company, today announced its financial and operating results for the first quarter ended March 31, 2026. Unless otherwise indicated, all financial results are presented in U.S. dollars.</p> <p align="justify"><strong>Management Commentary</strong><br />Cost reduction across the base business remained a top priority for the leadership team during Q1 2026, resulting in a year-over-year reduction of more than 20% in total operating expenses.</p> <p align="justify">"The Company remained focused on key strategic priorities in the quarter, including cost reductions, operational efficiencies, and broader b

Austin, Texas , May 26, 2026 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE MEDX HOLDINGS (MEDH) REPORTS EXCEPTIONAL Q1 2026 FINANCIALS: REVENUE SURGES, EXPANSION ON TRACK, AND CEO TO SPEAK AT HEMP BEVERAGE EXPO AUSTIN, Texas — May 26, 2026 — MedX Holdings, Inc. (OTC: MEDH ) (soon to be Dazed Inc., pending ticker symbol DAZE), a dynamic brands and acquisition company focused on the emerging hemp, cannabis, and hospitality industries, today announced its financial results for the first quarter ended March 31, 2026. The company is thrilled to report significant year-over-year revenue and gross profit growth, continued profitability, and major traction in its nationwide franchise expansion. Q1 2026 Financial Highlights: Accelerated Growth and Profitability The first quarter of 2026 reflects the power of MedX's strategic focus on high-margin branding, efficient operations, and calculated expansion. Key financial milestones from the Q1 2026 consolidated financial statements include: Solid Revenue Growth: Q1 2026 revenues reached $521,874, representing an impressive 52.7% increase compared to revenues of $341,711 in Q1 2025. Surging Gross Profit: Gross profit for the quarter climbed to $398,990, a 70.6% jump from the $233,793 reported in the same period last year. Sustained Profitability: The company maintained a positive bottom line, reporting a net income of $22,203 for the three months ended March 31, 2026. Expansion on Track: Bringing the "Third Place" to New Cities Following the momentum built in late 2025, ... Full story available on Benzinga.com

LSL Pharma Group Reports Record Q1-2026 Revenues while positioning for improved profitability following Steri-Med Pharma production resumption. Launch of new eye-drop portfolio planned for the second quarter of 2026. Secured US-FDA certification of Steri-Med to manufacture ophthalmic ointment for the US market. BOUCHERVILLE, QC , May 25, 2026 /CNW/ - LSL PHARMA GROUP INC . (TSXV: LSL ) (the " Corporation " or " LSL Pharma "), a Canadian integrated pharmaceutical company, today reported its financial results for the first quarter ended March 31, 2026 ("Q1-26"). All amounts are presented in millions ("M") of Canadian dollars. Q1-26 Corporate and Financial Highlights Record quarterly consolidated revenues, including full quarter contribution from Laboratoire Du-Var ("Du-Var") and Juno OTC acquired on January 1 st , 2026 and to be presented as 3 rd business segment; Strong Eye-Care revenues show significant market share gains in Canada; Q1-26 profitability temporarily impacted by the three-month Steri-Med Pharma (Steri-Med) production pause, with full production activities having resumed in April 2026; Secured US-FDA certification of Steri-Med to manufacture ophthalmic ointment for the US market; Commissioning of new state-of-the-art sterile ointment manufacturing line on track for commercial production by Q1-27; Development of three (3) new ointment products initiated for regulatory filings during FY-27. Binding term sheet signed with Instapill Private Limited ("Instapill") for the Canadian rights to private label Loratadine 10 mg Orally Disintegrating Tablets (ODT), a bioequivalent product to Claritin® Rapid Dissolve TM ; Revolving credit facility increased from $7.5M to $11M; "During the first quarter of 2026, we saw the positive impact of the recent acquisitions of Juno OTC and Du-Var on our operating results and the diversification of our business platform. Whil

Flyte, a regional air mobility company, announced full-scale activation of its Memorial Day flight network across the Northeast corridor, deploying aircraft on high-frequency short-haul routes including NYC to Nantucket, Hamptons, and Martha's Vineyard. The company aims to capture premium travel demand during the holiday weekend surge by offering sub-one-hour flights as an alternative to congested ground travel.

Bitget, the world's largest Universal Exchange, has launched the UEX Jumpstart Program, a multi-product onboarding initiative with a 430,000 USDT prize pool spanning crypto futures, precious metals, stocks, and CFDs. The program runs through June 2026 and reflects growing market diversification, with non-crypto assets accounting for 40% of Bitget's Q1 2026 trading volume.